These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 14558414)
1. [Levofloxacin (Tavanic) in the treatment of corneal ulcers]. Maĭchuk IuF Antibiot Khimioter; 2003; 48(6):16-9. PubMed ID: 14558414 [TBL] [Abstract][Full Text] [Related]
2. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group. Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124 [TBL] [Abstract][Full Text] [Related]
3. [Lomefloxacin in treatment of infectious eye diseases]. Maĭchuk IuF; Vakhova ES; Kononenko LA Antibiot Khimioter; 1998; 43(10):32-5. PubMed ID: 9825108 [TBL] [Abstract][Full Text] [Related]
10. The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery. Holland EJ; McCarthy M; Holland S Curr Med Res Opin; 2007 Dec; 23(12):2955-60. PubMed ID: 17939882 [TBL] [Abstract][Full Text] [Related]
11. Sparfloxacin and levofloxacin. Med Lett Drugs Ther; 1997 Apr; 39(999):41-3. PubMed ID: 9137295 [No Abstract] [Full Text] [Related]
12. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Panda A; Ahuja R; Sastry SS Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183 [TBL] [Abstract][Full Text] [Related]
14. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis. Khokhar S; Sindhu N; Mirdha BR Infection; 2000; 28(3):149-52. PubMed ID: 10879638 [TBL] [Abstract][Full Text] [Related]
15. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]. Scheen AJ Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704 [TBL] [Abstract][Full Text] [Related]
16. A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection. Klimberg IW; Cox CE; Fowler CL; King W; Kim SS; Callery-D'Amico S Urology; 1998 Apr; 51(4):610-5. PubMed ID: 9586615 [TBL] [Abstract][Full Text] [Related]
17. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits. Jensen H; Zerouala C; Carrier M; Short B J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits. Wada T; Kozai S; Tajika T; Sakaki H; Suzuki T; Ohashi Y J Ocul Pharmacol Ther; 2008 Jun; 24(3):278-89. PubMed ID: 18462067 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology]. Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns]. Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]